124 related articles for article (PubMed ID: 19011336)
1. [Team-based medical care can improve tailor made chemotherapy for colorectal cancer].
Muneoka K; Shirai Y; Sasaki M; Kanda J; Asakura T; Wakabayashi H; Toshima M; Hatakeyama K
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1883-7. PubMed ID: 19011336
[TBL] [Abstract][Full Text] [Related]
2. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for operable and advanced colorectal cancer.
Aschele C; Bergamo F; Lonardi S
Cancer Treat Rev; 2009 Oct; 35(6):509-16. PubMed ID: 19481872
[TBL] [Abstract][Full Text] [Related]
4. [The team medical support in out-patient chemotherapy: a role of nurses].
Doi N; Shigematsu T; Amamori K; Yamada T; Hattori N; Morisaki S; Matsuo A; Hatai Y; Senba I; Shirai M
Gan To Kagaku Ryoho; 2007 Dec; 34 Suppl 2():242-4. PubMed ID: 20443275
[TBL] [Abstract][Full Text] [Related]
5. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
6. [Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
Arakawa Y; Sakuyama T; Ichiba T; Inoue D; Kobayashi T; Aiba K
Gan To Kagaku Ryoho; 2007 Dec; 34 Suppl 2():245-7. PubMed ID: 20443276
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic chemotherapy for incurable colorectal cancer: living with a PICC-line.
Molloy D; Smith LN; Aitchison T
J Clin Nurs; 2008 Sep; 17(18):2398-407. PubMed ID: 18705719
[TBL] [Abstract][Full Text] [Related]
10. [Second-line chemotherapy for colorectal cancer].
Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
Sorbye H; Pfeiffer P; Cavalli-Björkman N; Qvortrup C; Holsen MH; Wentzel-Larsen T; Glimelius B
Cancer; 2009 Oct; 115(20):4679-87. PubMed ID: 19562777
[TBL] [Abstract][Full Text] [Related]
13. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
14. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
[TBL] [Abstract][Full Text] [Related]
16. [Significance of Onodera's prognostic nutritional index for treating unresectable or recurrent colorectal cancer with chemotherapy].
Okada I; Shirahata A; Soda H; Saitou M; Kigawa G; Nemoto H; Sanada Y; Hibi K
Gan To Kagaku Ryoho; 2012 Feb; 39(2):231-5. PubMed ID: 22333633
[TBL] [Abstract][Full Text] [Related]
17. Progress in the medical treatment of advanced colorectal cancer.
Fabre-Guillevin E; Piedbois P; Buyse M
Expert Rev Anticancer Ther; 2003 Oct; 3(5):711-6. PubMed ID: 14599093
[TBL] [Abstract][Full Text] [Related]
18. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
[TBL] [Abstract][Full Text] [Related]
19. [Questionnaire survey of systemic chemotherapy in colorectal cancer].
Katoh K; Morita T; Kameyama M; Watanabe M; Yoshioka K; Hirai T; Takao Y; Sunouchi K; Ogata Y; Tomita N; Siroto H; Akasu T; Ikeuchi K; Takahashi K; Kubo R
Gan To Kagaku Ryoho; 2002 Jun; 29(6):895-903. PubMed ID: 12090041
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for nonresectable colorectal cancer at a center during 25 years.
Edna TH; Jullumströ E; Lydersen S
Hepatogastroenterology; 2008; 55(88):2049-53. PubMed ID: 19260475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
